Clinical Study to Evaluate XS411 in Treatment of Early-onset Parkinson's Disease
Clinical Study to Evaluate XS411 in Treatment of Early-onset Parkinson's Disease
Recruiting · NCT07166757 · Registry updated 2025-12-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Clinical Study to Evaluate XS411 in Treatment of Early-onset Parkinson's Disease | Parkinson disease, basal ganglia disorder, brain disorder, central nervous system disorder, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, synucleinopathy | Recruiting | Phase 1 / Phase 2 | 2025-12-29 | NCT07166757 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd. | 5 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Huashan Hospital, Fudan University | Shanghai | China | 40 |